Trials / Completed
CompletedNCT02041754
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
Double Blind, Randomized, Placebo-controlled, Monocentric Clinical Investigation to Evaluate Efficacy of IQP-AK-102 on Appetite Reduction in Healthy Overweight and Obese Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The individual ingredients in IQP-AK-102 have been widely used. Backed by data from several studies demonstrating their efficacy, we are conducting this study to look into the efficacy and safety of this novel combination of three fibres, in appetite regulation, aiming to reduce the appetite.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IQP-AK-102 | |
| DEVICE | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-01-22
- Last updated
- 2015-03-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02041754. Inclusion in this directory is not an endorsement.